Drugs / autologous mesenchymal stromal cell
autologous mesenchymal stromal cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02384018 | Dec 2014 → Jun 2016 | chronic pancreatitis, diabetes mellitus | Medical University of South Carolina | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous mesenchymal stromal cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02384018 ↗ |
| Known as | BM-MSCs | “autologous BM-MSCs in chronic pancreatitis patients” NCT02384018 ↗ |
| Known as | mesenchymal stem cells | “cotransplantation of ex vivo expanded autologous bone marrow-derived mesenchymal stem cells (MSCs) with islets” PMID 29159905 ↗ Nov 2017 |
| Known as | MSCs | “cotransplantation of ex vivo expanded autologous bone marrow-derived mesenchymal stem cells (MSCs) with islets” PMID 29159905 ↗ Nov 2017 |
| Modality | Cell therapy | “cotransplantation of ex vivo expanded autologous bone marrow-derived mesenchymal stem cells (MSCs) with islets” PMID 29159905 ↗ Nov 2017 |
| Route | Other | “MSCs was infused with islets via the portal vein” PMID 29159905 ↗ Nov 2017 |